image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 2.98
2.76 %
$ 52.6 M
Market Cap
-2.92
P/E
CASH FLOW STATEMENT
-14.5 M OPERATING CASH FLOW
55.01%
-804 K INVESTING CASH FLOW
81.38%
-10.6 M FINANCING CASH FLOW
-2074.23%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Exagen Inc.
image
Net Income -23.7 M
Depreciation & Amortization 2.17 M
Capital Expenditures -828 K
Stock-Based Compensation 3.62 M
Change in Working Capital 325 K
Others 3.85 M
Free Cash Flow -15.3 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2015 Dec-2014 Dec-2013 Dec-2012
OPERATING CASH FLOW
Net Income (23.7) (47.4) (26.9) (16.7) (12.0) (8.0) (25.6) (19.2) (15.0) (13.5) (7.3)
Depreciation & Amortization 2.2 1.6 0.9 0.5 0.6 0.7 0.7 0.9 0.6 0.5 0.4
Deferred Income Tax 0 (0.3) 0.1 (0.1) (0.2) 31 K (0.6) 0.3 14 K 42 K 42 K
Stock Based Compensation 3.6 4.7 4.7 2.7 0.6 0.1 0.2 0.3 0.3 0.2 0.1
Other Operating Activities 3.1 7.6 0.8 0.8 1.2 1.4 16.4 6.8 1.7 5.2 (0.3)
Change in Working Capital 0.3 1.7 61 K (1.3) 0.2 (3.6) (2.0) (0.9) 1.7 0.8 (0.4)
Cash From Operations (14.5) (32.1) (20.3) (14.1) (9.7) (9.3) (11.0) (11.9) (10.8) (6.9) (7.5)
INVESTING CASH FLOW
Capital Expenditures (0.8) (4.3) (2.4) (0.5) (0.4) (0.2) (0.6) (0.8) (0.6) (0.2) (0.4)
Other Items 24 K 0 50 K 0 0.3 0 57 K 5 K 0 0.7 (0.7)
Cash From Investing Activities (0.8) (4.3) (2.4) (0.5) (0.1) (0.2) (0.5) (0.8) (0.6) 0.5 (1.1)
FINANCING CASH FLOW
Common Stock Repurchased 0.3 (0.2) 0 0.1 0 0 0 0 0 0 0
Total Debt Repaid (10.9) (0.7) (0.5) (0.2) (0.1) 5.0 4.5 10.7 8.7 7.4 (0.6)
Dividends Paid 0 0 0 0 (6.7) 0 0 0 0 0 0
Other Financing Activities 0.3 0.2 (3.9) 0.2 18.4 12.9 25.5 (0.1) (0.6) 6.4 7.8
Cash From Financing Activities (10.6) (0.5) 64.7 97 K 68.7 11.4 19.2 10.6 8.3 11.3 7.3
CHANGE IN CASH
Net Change In Cash (25.9) (37.0) 42.0 (14.6) 58.9 1.9 7.7 (2.1) (3.1) 5.0 (1.4)
FREE CASH FLOW
Free Cash Flow (15.3) (36.5) (22.6) (14.5) (10.1) (9.5) (11.5) (12.7) (11.4) (7.0) (7.9)